Letko, Brosseau & Associates’s Avanos Medical AVNS Stock Holding History

Letko, Brosseau & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-77,533	Closed	-$2.52M	–	100
2016 Q2	$2.52M	Sell	77,533 -1,910	-2%	-$58.5K	0.02%	82
2016 Q1	$2.28M	Sell	79,443 -9,909	-11%	-$264K	0.02%	85
2015 Q4	$2.98M	Sell	89,352 -7,958	-8%	-$247K	0.03%	85
2015 Q3	$2.77M	Sell	97,310 -11,507	-11%	-$401K	0.03%	83
2015 Q2	$4.41M	Sell	108,817 -20,257	-16%	-$909K	0.04%	81
2015 Q1	$6.35M	Sell	129,074 -33,477	-21%	-$1.55M	0.06%	80
2014 Q4	$7.39M	Buy	+162,551	New	+$6.39M	0.06%	78

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Letko, Brosseau & Associates's AVNS Position: Q3 2016 in Review

Letko, Brosseau & Associates sold out of Avanos Medical (AVNS) in Q3 2016, closing a stake of 77,533 shares — an estimated $2.52M sold.

Letko, Brosseau & Associates first reported a position in AVNS in Q4 2014 and held it in 7 quarters. The position peaked at $7.39M in Q4 2014. 359 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

Letko, Brosseau & Associates reported no remaining Avanos Medical position as of Q3 2016 after selling out during the quarter.
Letko, Brosseau & Associates sold 77,533 Avanos Medical shares in Q3 2016, an estimated $2.52M.
Letko, Brosseau & Associates first reported a position in Avanos Medical in Q4 2014 and held it in 7 quarters.
Letko, Brosseau & Associates's Avanos Medical position peaked at $7.39M in Q4 2014.
359 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.